Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α

Zhao, Shimin, Lin, Yan, Xu, Wei, Jiang, Wenqing, Zha, Zhengyu, Wang, Pu, Yu, Wei, Li, Zhiqiang, Gong, Lingling, Peng, Yingjie, Ding, Jianping, Lei, Qunying, Guan, Kun-Liang, Xiong, Yue·2009·Science

DOI 10.1126/science.1170944

Cited by (999)

Items 601–700 of 999

Cancer metabolism in a snapshot: MRS(I)
Margarida Julià‐Sapé, Ana Paula Candiota, Carles Arús · 2019 · NMR in Biomedicine
Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI
X. Wang, X.-Z. Chen, Lin Shi, Jianping Dai · 2019 · Clinical Radiology
The Multifaceted Glioblastoma: From Genomic Alterations to Metabolic Adaptations
Addison Quinones, Anne Le · 2021 · Advances in experimental medicine and biology
In Vivo Imaging of Hypoxia-Inducible Factor Regulation in a Subcutaneous and Orthotopic GL261 Glioma Tumor Model Using a Reporter Gene Assay
Sandra Bürgi, Aline Seuwen, Ruth Keist, Johannes vom Berg, Joanes Grandjean, Markus Rudin · 2014 · Molecular Imaging
Metabolic, autophagic, and mitophagic activities in cancer initiation and progression
Anita B. Hjelmeland, Jianhua Zhang · 2016 · Biomedical Journal
Epigenetic methylations and their connections with metabolism
Fulvio Chiacchiera, Andrea Piunti, Diego Pasini · 2013 · Cellular and Molecular Life Sciences
Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
Oliver Fiehn, Megan Reed Showalter, Christine E. Schaner Tooley, Reproducibility Project: Cancer Biology · 2016 · eLife
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
Siobhan Conroy, Michiel Wagemakers, Annemiek Walenkamp, Frank A.E. Kruyt, Wilfred F.A. den Dunnen · 2016 · Journal of Neuro-Oncology
IDH1 Mutation Is an Independent Inferior Prognostic Indicator for Patients with Myelodysplastic Syndromes
Na Wang, Fei Wang, Ning‐ning Shan, Xiaohui Sui, Hongzhi Xu · 2017 · Acta Haematologica
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas
Olatz Etxániz, Cristina Carrato, Itziar de Aguirre, Cristina Queralt, Ana María Muñoz-Mármol, José Luis Ramírez, Rafael Rosell, S. Villà, R. Lasierra Díaz, Ana Estival et al. · 2017 · Journal of Neuro-Oncology
Characterization of cancer-associated IDH2 mutations that differ in tumorigenicity, chemosensitivity and 2-hydroxyglutarate production
Kevin P. Kotredes, Roshanak Razmpour, Evan M. Lutton, Mercedes Alfonso‐Prieto, Servio H. Ramirez, Ana M. Gamero · 2019 · Oncotarget
Tumor mutational burden predicts survival in patients with low-grade gliomas expressing mutated IDH1
Mahmoud S. Alghamri, Rohit Thalla, Ruthvik Avvari, Ali A. Dabaja, Ayman W. Taher, Lili Zhao, Peter Ulintz, Maria Graciela Castro, Pedro Ricardo Lowenstein · 2020 · Neuro-Oncology Advances
Hypoxic mitochondria: accomplices in resistance
Nathalie M. Mazure, M. Christiane Brahimi-Horn, Jacques Pouysségur · 2011 · Bulletin du Cancer
Isocitrate dehydrogenase 1: what it means to the neurosurgeon
Tiffany R. Hodges, Bryan D. Choi, Darell D. Bigner, Hai Yan, John Howard Sampson · 2013 · Journal of neurosurgery
Molecular markers in gliomas: impact for the clinician
Silvia Höfer, Andrew B. Lassman · 2010 · Targeted Oncology
Isocitrate dehydrogenase mutations in chondrosarcoma
Georges Azzi, Michel Velez, Maria Cecília Mathias-Machado · 2014 · Current Opinion in Oncology
Prediction of Overall Survival Based on Isocitrate Dehydrogenase 1 Mutation and 18F-FDG Uptake on PET/CT in Patients With Cerebral Gliomas
Dongwoo Kim, Soyoung Kim, Se Hoon Kim, Jong Hee Chang, Mijin Yun · 2018 · Clinical Nuclear Medicine
d-2-Hydroxyglutarate dehydrogenase plays a dual role in l-serine biosynthesis and d-malate utilization in the bacterium Pseudomonas stutzeri
Xiaoting Guo, Manman Zhang, Menghao Cao, Wen Zhang, Zhaoqi Kang, Ping Xu, Cuiqing Ma, Chao Gao · 2018 · Journal of Biological Chemistry
Large-Scale Drug Screening in Patient-Derived IDHmut Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents
Philip Dao Trong, Gerhard Jungwirth, Tao Yu, Stefan Pusch, Andreas Wilhelm Unterberg, Christel C. Herold‐Mende, Rolf Warta · 2020 · Cells
Relapsing High—Grade Glioma from Peritumoral Zone: Critical Review of Radiotherapy Treatment Options
Maria Chiara Lo Greco, Roberto Milazzotto, Rocco Luca Emanuele Liardo, Grazia Acquaviva, Madalina La Rocca, Roberto Altieri, Francesco Certo, Giuseppe Maria Vincenzo Barbagallo, Antonio Basile, Pietro Valerio Foti et al. · 2022 · Brain Sciences
The role of mutation of metabolism-related genes in genomic hypermethylation
Joshua J. Waterfall, J. Keith Killian, Paul S. Meltzer · 2014 · Biochemical and Biophysical Research Communications
IDH1 mutant structures reveal a mechanism of dominant inhibition
Shimin Zhao, Kun‐Liang Guan · 2010 · Cell Research
Exploiting Metabolic Differences in Glioma Therapy
Francesca Galeffi, Dennis A. Turner · 2012 · Current Drug Discovery Technologies
Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Jose Ignacio Piruat, África Millán‐Uclés · 2014 · Frontiers in Oncology
Isocitrate dehydrogenase mutations may be a protective mechanism in glioma patients
Jian Zhu, Jianling Zuo, Qinian Xu, Xiuyun Wang, Zhong Wang, Dai Zhou · 2011 · Medical Hypotheses
The molecular biology of WHO grade II gliomas.
Nicholas F. Marko, R. Weil · 2013 · Neurosurgical Focus
Genomic, epigenomic and transcriptomic landscape of glioblastoma
Tikam Chand Dakal, Ganesh S. Kakde, Pawan Kumar Maurya · 2024 · Metabolic Brain Disease
Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma
Chen Zhu, Xin Chen, Tianqi Liu, Lin Li Cheng, Wen Cheng, Peng Cheng, Anhua Wu · 2024 · Nature Communications
Hypoxia Promotes Pancreatic Cancer Cell Dedifferentiation to Stem-Like Cell Phenotypes With High Tumorigenic Potential by the HIF-1α/Notch Signaling Pathway
Rui Mu, Yongkang Zou, Kui Tu, Dian-Bei Wang, Dan Tang, Yu Zhou, Lijin Zhao · 2021 · Pancreas
Disabling Uncompetitive Inhibition of Oncogenic IDH Mutations Drives Acquired Resistance
Junhua Lyu, Yuxuan Liu, Lihu Gong, Mingyi Chen, Yazan F. Madanat, Yuannyu Zhang, Feng Cai, Zhimin Gu, Hui Cao, Pranita Kaphle et al. · 2022 · Cancer Discovery
Exploring the functional roles of small-molecule metabolites in disease research: Recent advancements in metabolomics
Aolei Tan, Xiaoxiao Ma · 2023 · Chinese Chemical Letters
Cancer genomics identifies determinants of tumor biology
Elaine R. Mardis · 2010 · Genome biology
Prognostic Markers in Gliomas
Marianne Labussière, Xiao-Wei Wang, Ahmed Idbaïh, François Ducray, Marc Sanson · 2010 · Future Oncology
Proteomic analysis of oligodendrogliomas expressing a mutant isocitrate dehydrogenase‐1
Cécile Thirant, Pascale Varlet, Joanna Lipecka, Morgane Le Gall, Cédric Broussard, Philippe Chafey, Jeanne‐Marie Studler, Joëlle Lacombe, Séverin Lions, Angélique Guillaudeau et al. · 2011 · PROTEOMICS
2-Hydroxyglutarate inIDHmutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels
Daniel Aaron Pollyea, Holbrook E K Kohrt, Bing Melody Zhang, James L. Zehnder, David P. Schenkein, Valeria R. Fantin, Kimberly S. Straley, Aparna Vasanthakumar, Omar Ibrahim Abdel-Wahab, Ross L. Levine et al. · 2012 · Leukemia & lymphoma/Leukemia and lymphoma
Cyst Fluid From Cystic, Malignant Brain Tumors: A Reservoir of Nutrients, Including Growth Factor-Like Nutrients, for Tumor Cells
Daniel Dahlberg, Eduard A. Struys, Erwin E. W. Jansen, Lars Mørkrid, Øivind Midttun, Bjørnar Hassel · 2017 · Neurosurgery
Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation
Chiung‐Kuei Huang, Yoshifumi Iwagami, Jing Zou, Sarah Casulli, Shaolei Lu, Katsuya Nagaoka, Chengcheng Ji, Kousuke Ogawa, Kevin Y. Cao, Jinsong Gao et al. · 2018 · Cancer Letters
Isocitrate dehydrogenase 1 mutation is associated with reduced levels of inflammation in glioma patients
Raushan Auezova, Natalia Evgenievna Ivanova, Serik Akshulakov, Б Б Жетписбаев, Aizhan Kozhakhmetova, Nurzhan Ryskeldiyev, Khalit Mustafin, Daniyar Teltayev, Lizette Auezova · 2019 · Cancer Management and Research
On the Relevance of Glycolysis Process on Brain Gliomas
M. G. Kounelakis, Michalis E. Zervakis, G. C. Giakos, Geert Postma, L.M.C. Buydens, Xenofon Kotsiakis · 2013 · IEEE Journal of Biomedical and Health Informatics
Development of amperometric α-ketoglutarate biosensor based on ruthenium–rhodium modified carbon fiber enzyme microelectrode
Sujittra Poorahong, Padmanabhan Santhosh, Gabriela Valdés‐Ramírez, Ta-Feng Tseng, Joseph Isaac Wong, Proespichaya Kanatharana, Panote Thavarungkul, Joseph Wang · 2011 · Biosensors and Bioelectronics
Progress on molecular biomarkers and classification of malignant gliomas
Chuanbao Zhang, Zhaoshi Bao, Wei Zhang, Tao Jiang · 2013 · Frontiers of Medicine
Pharmacological characterization of TQ 05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants
Mingzhao Gao, Hongmei Zhu, Fu Li, Yun Li, Xubin Bao, Haoyu Fu, Haitian Quan, Lei Wang, Liguang Lou · 2019 · Cancer Science
Prognostic impact of IDH mutations in chondrosarcoma
Makoto Nakagawa, Masaya Sekimizu, Makoto Endo, Eisuke Kobayashi, Shintaro Iwata, Suguru Fukushima, Akihiko Yoshida, Issay Kitabayashi, Hitoshi Ichikawa, Akira Kawai et al. · 2021 · Journal of Orthopaedic Science
Complex role of HIF in cancer: the known, the unknown, and the unexpected
Eric L. Huang, Patricia D.B. Tiburcio, Hyunsung Choi · 2014 · Hypoxia
Isocitrate dehydrogenase 1 R132H mutation is not detected in angiocentric glioma
Aditya Raghunathan, Adriana Olar, Hannes S. Vogel, John R. Parker, Susan C. Coventry, Robert Debski, Constance T. Albarracin, Kenneth Aldape, Daniel P. Cahill, Suzanne Zein-Eldin Powell et al. · 2012 · Annals of Diagnostic Pathology
Emerging Approaches for Targeting Metabolic Vulnerabilities in Malignant Glioma
Peter M. Clark, Wilson X. Mai, Timothy Francis Cloughesy, David A. Nathanson · 2016 · Current Neurology and Neuroscience Reports
Mitochondrial metabolic remodeling in response to genetic and environmental perturbations
Kate E.R. Hollinshead, Daniel A. Tennant · 2016 · WIREs Systems Biology and Medicine
Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy
Paul J. Akhenblit, Marty D. Pagel · 2016 · Journal of Cancer Science & Therapy
Isocitrate dehydrogenase 1 and 2 mutations in gliomas
Magdalena Megova Houdova, Jir̆ı́ Drábek, Vladimíra Koudeláková, Radek Trojanec, Ondřej Kalita, Marián Hajdúch · 2014 · Journal of Neuroscience Research
Genomic discoveries in adult astrocytoma
Joanna Wang, Chetan Bettegowda · 2015 · Current Opinion in Genetics & Development
Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio
Marike W. van Gisbergen, Emma Zwilling, Ludwig Jerome Dubois · 2021 · Frontiers in Oncology
Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1α axis
Xun Liu, Kiyoshi Yamaguchi, Kiyoko Takane, Chi Zhu, Makoto Hirata, Yoko Hikiba, Shin Maeda, Yoichi Furukawa, Tsuneo Ikenoue · 2021 · PLoS ONE
Targeting oncometabolism to maximize immunotherapy in malignant brain tumors
Joshua D. Bernstock, Kyung‐Don Kang, Neil V. Klinger, Hannah E. Olsen, Sam E. Gary, Stacie K. Totsch, Gelare Ghajar-Rahimi, David J. Segar, Eric M. Thompson, Victor M. Darley-Usmar et al. · 2022 · Oncogene
D-2-hydroxyglutarate dehydrogenase governs adult neural stem cell activation and promotes histone acetylation via ATP-citrate lyase
Yinghao Liu, Min Wang, Ye Guo, Lei Wang, Weixiang Guo · 2023 · Cell Reports
Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme
Mekala Janaki Ramaiah, Kowsalya Adusumilli, Sahiti Chamarthy, Hari Sai Ram Angirekula · 2023 · Metabolic Brain Disease
IDH1 mutation, a genetic alteration associated with adult gliomatosis cerebri
Deepti Narasimhaiah, Catherine Miquel, Elisabeth Verhamme, Paul Desclée, Guy Cosnard, Catherine Godfraind · 2011 · Neuropathology
A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders
Kenichi Yoshida, Masashi Sanada, Motohiro Kato, Ryoichiro Kawahata, Akio Matsubara, Jyunko Takita, L-Y Shih, H Mori, Harold Phillip Koeffler, S.Y. Ogawa · 2010 · Leukemia
Expression of R132H Mutational IDH1 in Human U87 Glioblastoma Cells Affects the SREBP1a Pathway and Induces Cellular Proliferation
Jian Zhu, Gang Cui, Ming Chen, Qinian Xu, Xiuyun Wang, Dai Zhou, Shengxiang Lv, Linshan Fu, Zhong Wang, Jianling Zuo · 2012 · Journal of Molecular Neuroscience
Metabolism and cancer: an up-to-date review of a mutual connection.
Alexios‐Fotios A. Mentis, Evangelia G. Kararizou · 2010 · PubMed
Molecular mechanisms involved in gliomagenesis
Tôru Kondo · 2017 · Brain Tumor Pathology
Molecular basis for the function of the αβ heterodimer of human NAD-dependent isocitrate dehydrogenase
Pengkai Sun, Tengfei Ma, Tianlong Zhang, Hanwen Zhu, Jianyang Zhang, Yabing Liu, Jianping Ding · 2019 · Journal of Biological Chemistry
The role of TET-mediated DNA hydroxymethylation in prostate cancer
Elien Smeets, Andy G. Lynch, Stefan Preković, Thomas Van den Broeck, Lisa Moris, Christine Helsen, Steven Joniau, Frank Claessens, Charlie E. Massie · 2017 · Molecular and Cellular Endocrinology
Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes
Peipei Lin, Yingwan Luo, Shuanghong Zhu, Dominic M. Maggio, Haiyang Yang, Chao Hu, Jinghan Wang, Hua Zhang, Yanling Ren, Xinping Zhou et al. · 2018 · Journal of Cancer Research and Clinical Oncology
Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis
Phuong Nhat Nguyen, Ngoc T.B. Tran, Truong Phan-Xuan Nguyen, Tam N.M. Ngo, Doan Van Lai, Chelsey D. Deel, Lewis Allen Hassell, Huy Gia Vuong · 2021 · Clinical Lymphoma Myeloma & Leukemia
Glutamate dehydrogenase1 supports HIF‐1α stability to promote colorectal tumorigenesis under hypoxia
Kunhua Hu, Yufeng Ding, Hongwen Zhu, Xiaoqian Jing, Weiling He, Hua Tao Yu, Xiongjun Wang · 2023 · The EMBO Journal
Glioma-derived mutations in isocitrate dehydrogenase 2 beneficial to traditional chemotherapy
Yuejun Fu, Rui Huang, Yali Zheng, Zhiyun Zhang, Aihua Liang · 2011 · Biochemical and Biophysical Research Communications
How do oncoprotein mutations rewire protein–protein interaction networks?
Emily Bowler-Barnett, Zhenghe Wang, Rob M. Ewing · 2015 · Expert Review of Proteomics
Enrichment of Aldolase C Correlates with Low Non-Mutated IDH1 Expression and Predicts a Favorable Prognosis in Glioblastomas
Yu‐Chan Chang, Hsing‐Fang Tsai, Shang‐Pen Huang, Chi‐Long Chen, Michael Hsiao, Wen‐Chiuan Tsai · 2019 · Cancers
Detection of isocitrate dehydrogenase 1 mutation R132H in myelodysplastic syndrome by mutation-specific antibody and direct sequencing
Mindaugas Andrulis, David Capper, Thomas Luft, Christian Johannes Hartmann, Hanswalter Zentgraf, Andreas von Deimling · 2010 · Leukemia Research
The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma
Wang, Yuxiong, Liu, Bin, Li, Faping, Zhang, Yanghe, Gao, Xin, Wang, Yishu, Zhou, Honglan · 2023 · Frontiers in Endocrinology
Distinct Roles of Glutamine Metabolism in Benign and Malignant Cartilage Tumors With IDH Mutations
Hongyuan Zhang, Vijitha Puviindran, Puviindran Nadesan, Xiruo Ding, Leyao Shen, Yuning J. Tang, Hidetoshi Tsushima, Yasuhito Yahara, Ga I Ban, Guofang Zhang et al. · 2020 · Journal of Bone and Mineral Research
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
Mahmoud Adel Bassal · 2023 · Biomolecules
Stem Cells in Brain Tumor Development
Sheila R. Alcantara Llaguno, Yuntao Chen, Renée M. McKay, Luis F. Parada · 2011 · Current topics in developmental biology/Current Topics in Developmental Biology
Diagnostic and prognostic markers in gliomas – an update
Ruichong Ma, Nick de Pennington, Monika Hofer, Claire Blesing, Richard J. Stacey · 2013 · British Journal of Neurosurgery
Mutations in isocitrate dehydrogenase 2 accelerate glioma cell migration via matrix metalloproteinase-2 and 9
Yuejun Fu, Yali Zheng, Ke Li, Rui Huang, Shuhua Zheng, Na An, Aihua Liang · 2011 · Biotechnology Letters
Rapid and reliable detection of IDH1 R132 mutations in acute myeloid leukemia using high-resolution melting curve analysis
Jiang Lin, Jun Qian, Dong‐ming Yao, Yun Li, Jing Chun Yang, Qin Chen, Hai‐yan Chai, Gao-fei Xiao, Wenrong Xu · 2011 · Clinical Biochemistry
Actualités dans la biologie, l’imagerie et le traitement des gliomes de l’adulte
François Ducray, Guillaume Dutertre, Damien Ricard, E. Gontier, Ahmed Idbaïh, Christophe Massard · 2010 · Bulletin du Cancer
Molecular Diagnostic and Prognostic Subtyping of Gliomas in Tunisian Population
Saoussen Trabelsi, Imen Chabchoub, Iadh Ksira, Nadhir Karmeni, N. Mama, Samia Kanoun, Anna Burford, Alexa Jury, Alan G. Mackay, Sergey Popov et al. · 2016 · Molecular Neurobiology
Targeted Differentiation Therapy with Mutant IDH Inhibitors: Early Experiences and Parallels with Other Differentiation Agents
Eytan M. Stein, Katharine E. Yen · 2017 · Annual Review of Cancer Biology
Molecular mechanisms of retinal ischemia
Seth D. Fortmann, Maria B. Grant · 2018 · Current Opinion in Physiology
Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups*
Yu Liu, Zhigui Li, Zhiqiang Xu, Xiuxiu Jin, Yanqiu Gong, Xuyang Xia, Yuqin Yao, Zhaofen Xu, Yong Zhou, Heng Xu et al. · 2019 · Molecular & Cellular Proteomics
Potential implications of hydrogen peroxide in the pathogenesis and therapeutic strategies of gliomas
Ying Zhou, Long Wang, Chaojia Wang, Yilin Wu, Dongmei Chen, Tae Ho Lee · 2020 · Archives of Pharmacal Research
The role of α-ketoglutarate and the hypoxia sensing pathway in the regulation of pancreatic β-cell function
Monica Hoang, Jamie W. Joseph · 2020 · Islets
Metabolomics of Glioma
Sizhe Feng, Yutong Liu · 2021 · Advances in experimental medicine and biology
The non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer
Mengchao Yu, Jie Lun, Hongwei Zhang, Lei Zhu, Gang Zhang, Jing Susan Fang · 2021 · The International Journal of Biochemistry & Cell Biology
Interplay Between Glucose Metabolism and Chromatin Modifications in Cancer
Rui Ma, Yinsheng Wu, Shanshan Li, Xilan Yu · 2021 · Frontiers in Cell and Developmental Biology
Research Progress of Gliomas in Machine Learning
Yameng Wu, Yu Feng Guo, Jun Ma, Yu Sa, Qifeng Li, Ning Zhang · 2021 · Cells
Advances in the Immunotherapeutic Potential of Isocitrate Dehydrogenase Mutations in Glioma
Feng Ru Tang, Zhiyong Pan, Yi Wang, Tian Lan, Mengyue Wang, Fengping Li, Wei Quan, Zhen‐Yuan Liu, Zefen Wang, Zhiqiang Li · 2022 · Neuroscience Bulletin
Imaging Genomics of Glioblastoma
Safwan Moton, Mohamed Elbanan, Pascal Olivier Zinn, Rivka R. Colen · 2015 · Topics in Magnetic Resonance Imaging
Withaferin A suppresses tumor promoter 12‐ O ‐tetradecanoylphorbol 13‐acetate‐induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB 6 cells
Wenjuan Li, Yunfeng Zhao · 2012 · Cancer Science
DNA–PK facilitates piggyBac transposition by promoting paired-end complex formation
Yan Jin, Yaohui Chen, Shimin Zhao, Kun‐Liang Guan, Yuan Zhuang, Wenhao Zhou, Xiaohui Wu, Tian Xu · 2017 · Proceedings of the National Academy of Sciences
Distinct Phenotypic Clusters of Glioblastoma Growth and Response Kinetics Predict Survival
Corbin A. Rayfield, Fillan S. Grady, Gustavo De Leon, Russell C. Rockne, Eduardo Carrasco, Pamela Jackson, Mayur Vora, Sandra K. Johnston, Andrea J. Hawkins-Daarud, Kamala R. Clark-Swanson et al. · 2018 · JCO Clinical Cancer Informatics
Malignant Intracranial High Grade Glioma and Current Treatment Strategy
Xiang Zhang, Wei Zhang, Xinggang Mao, Weidong Cao, Haining Zhen, Shijie Hu · 2018 · Current Cancer Drug Targets
Metabolism of glioblastoma: a review of metabolic adaptations and metabolic therapeutic interventions
James Chung, Jawad Saad, Ahmad Kafri, Julien Rossignol, Maxwell Verbrugge, Jesse Bakke · 2025 · Frontiers in Oncology
Local and systemic effects of IDH mutations on primary glioma patients
Feng Ru Tang, Danwen Wang, Xi Chen, Jin‐Zhou Yang, Zhen‐Yuan Liu, Donghu Yu, Ze‐Fen Wang, Zhiqiang Li · 2023 · Immunology
Understanding serine and glycine metabolism in cancer: a path towards precision medicine to improve patient’s outcomes
Anaís Sánchez‐Castillo, Kim Rosalie Kampen · 2024 · Discover Oncology
Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer
Jieying Li, Jianfei Huang, Fang Huang, Qing Jin, Huijun Zhu, Xudong Wang, Meng Chen · 2016 · Oncotarget
Association of tumor growth rates with molecular biomarker status: a longitudinal study of high-grade glioma
Ziwen Fan, Yukun Liu, Shaowu Li, Xing Liu, Tao Jiang, Yinyan Wang, Lei Wang · 2020 · Aging
Metabolomic comparison between cells over‐expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism
He Wen, Hye Rim Cho, Taeho Yun, Hyeonjin Kim, Chul‐Kee Park, Se‐Hoon Lee, Seung Hong Choi, Sunghyouk Park · 2014 · Journal of Neurochemistry
A lymphoblast model for IDH2 gain-of-function activity in d-2-hydroxyglutaric aciduria type II: Novel avenues for biochemical and therapeutic studies
Martijn Kranendijk, Gajja Sophi Salomons, K. Michael Gibson, Emile VAN SCHAFTINGEN, Cornelis Jakobs, Eduard A. Struys · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease